ClinicalTrials.Veeva

Menu

A Validation Study to Evaluate the Performance of Caption Health Lung Guidance and Interpretation

C

Caption Health

Status

Enrolling

Conditions

Shortness of Breath

Treatments

Device: Caption LungAI

Study type

Interventional

Funder types

Industry

Identifiers

NCT05992324
LungPivotal

Details and patient eligibility

About

The purpose of this study is to assess the efficacy of Caption LungAI.

Full description

After being informed about the study, all patients giving written informed consent will undergo two 8-zone protocol lung ultrasound exams. One exam will be conducted by an expert lung ultrasound user without Caption LungAI and one exam conducted by a (non-expert) healthcare provider who is trained on Caption LungAI and will use Caption LungAI to capture images.

Enrollment

220 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients over the age of 18
  • Patients presenting to the hospital or outpatient setting with shortness of breath and suspected B-lines.

Exclusion criteria

  • Patients in extremis/in whom a research lung ultrasound would not normally be performed due to other priorities

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

220 participants in 1 patient group

Patients presenting with clinical suspicion of B-Lines
Experimental group
Description:
Patients will undergo two 8-zone protocol lung ultrasound exams. One exam will be conducted by an expert lung ultrasound user without Caption LungAI and will last approximately 5-10 minutes. The second exam will be conducted by a healthcare professional with Caption LungAI and will last approximately 15-20 minutes.
Treatment:
Device: Caption LungAI

Trial contacts and locations

4

Loading...

Central trial contact

Angeline Trinidad

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems